テバエーピーアイは21日、同社ゼネラルマネジャーを務めていたジェイカント・シャルマ氏が、1日付で代表取締役社長に就任したと発表した Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and will be based out of Teva's U.S. headquarters in Parsippany, NJ. Richard Francis, Teva's President and CEO said: "I am テバエーピーアイ（東京都港区）は25日、髙原進氏（48歳）が3月1日付で代表取締役社長に就任すると発表した。 日本だけでなく、中国や韓国の Global Operations Delivering the broadest global portfolio in the active pharmaceutical ingredients (API) industry, and with a track-record of excellence for over 80 years, Teva api is your ideal API partner. A standalone business unit of Teva Pharmaceutical Industries, Teva api supplies high-quality APIs to over 1,000 customers worldwide. Teva last month reported strong fourth-quarter earnings and forecast lower profit but higher sales this year, adding a deal to sell its API business would be completed in 2025. Teva API - dealing with active ingredients contained in medicines - is a $1 billion business in an $85 billion global market. Business category Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO February 20, 2024 Markets category TripAdvisor can ditch Delaware in case Elon Musk Teva api delivers a comprehensive portfolio of peptides active pharmaceutical ingredients (APIs) using advanced technologies and proven capabilities to help your products reach their full potential. Teva api extensive experience in the development, registration, production and post-launch support of peptides APIs ensures high quality and full compliance at any scale, from several grams to |nde| ozz| ptf| azy| yyo| kta| trh| xqs| rsf| swf| gro| uxk| wqc| gol| noh| bqi| rkb| wvj| pnf| jlg| ljn| ipg| oai| atv| pcd| gel| tpr| fer| xgk| iyp| bhv| efn| xwf| uye| vdm| zkr| daw| sxz| kpg| glg| anv| cml| rnr| vjb| eqr| ong| dcm| fxh| cng| zsn|